Home/Filings/4/0001209191-22-039565
4//SEC Filing

NARACHI MICHAEL 4

Accession 0001209191-22-039565

CIK 0001515673other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 1:51 PM ET

Size

7.1 KB

Accession

0001209191-22-039565

Insider Transaction Report

Form 4
Period: 2022-06-24
Transactions
  • Award

    Common Stock

    2022-06-24+3,30017,745 total
  • Award

    Stock Option (Right to Buy)

    2022-06-24+6,2456,245 total
    Exercise: $60.57Exp: 2032-06-24Common Stock (6,245 underlying)
Footnotes (2)
  • [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.
  • [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001380022

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 1:51 PM ET
Size
7.1 KB